Hensoldt’s Order Book Tops €10 Billion, Yet the Stock Can’t Shake Off the Sector’s Gloom

The disconnect could hardly be starker. Hensoldt’s order intake has doubled within twelve months, its backlog has breached a symbolic milestone, and its Optronics division has posted numbers that would make most defence executives blush. And still, the shares keep sliding.

That paradox has come to define the German defence electronics group’s market narrative in recent weeks. The stock closed Friday at €80.40, down 1.7 percent on the day and 7.7 percent lower on the week, leaving it roughly 32 percent beneath the 52-week high of €117.70 touched in early October. The relative strength index sits at 37.2, a technically oversold reading that has so far failed to trigger any meaningful stabilisation.

A Backlog Milestone That Failed to Move the Needle

The operational picture, laid out in the half-year results published in late July, is one of breakneck expansion. Hensoldt booked €2.812 billion in orders during the first six months of 2026 — double the year-earlier figure — pushing the order backlog above €10 billion for the first time. The book-to-bill ratio came in at 2.4x, comfortably ahead of the company’s own 1.5 to 2.0x target corridor.

Revenue climbed 23.6 percent to €1.167 billion, while adjusted EBITDA rose 28.5 percent to €137 million, translating into an 11.8 percent margin. The Optronics segment proved the standout performer: order intake surged from €164 million to €971 million, propelled by contracts for the Puma and Schakal systems, while the division’s margin leapt from 1.0 percent to 10.9 percent.

Management, led by CEO Dörre and CFO Ladurner, reaffirmed its full-year guidance of roughly €2.750 billion in revenue and an EBITDA margin between 18.5 and 19.0 percent. The company also raised its 2026 cash conversion target from 40 to 50 percent of adjusted EBITDA. Free cash flow remained negative at minus €136 million, though that represented a quarter-on-quarter improvement.

The market’s muted response to these figures — the shares have gained just 0.8 percent since the release — suggests investors had already priced in much of the strength. The second-quarter numbers themselves, with revenue of €671 million and earnings per share of €0.07 against a year-earlier loss of €0.10, did little to alter that calculus.

Sector Headwinds Trump Single-Stock Catalysts

Part of the explanation lies beyond Hensoldt’s own walls. The recent slide unfolded amid a broad sell-off in MDAX defence names, with Renk and TKMS among the other casualties. No company-specific trigger was identifiable for the move; it was, by all accounts, a sector-wide de-risking.

Should investors sell immediately? Or is it worth buying Hensoldt?

That dynamic has also neutralised what would ordinarily be considered positive news flow. A firm order for the avionics package of India’s ePlane e200X electric vertical take-off and landing project — a notable step toward civilian diversification beyond the core defence franchise — failed to provide any lift when announced on the Monday before the weekly decline. The contract, awarded by India’s ePlane Company, underscores Hensoldt’s efforts to broaden its commercial footprint, but investors appear unwilling to treat individual order announcements as standalone buying catalysts while the broader sentiment toward European defence equities remains bruised.

Management has also had to manage expectations around specific programme headwinds. The cancellation of the F126 programme, which Hensoldt quantified at roughly €130 million of backlog, was dismissed as immaterial, with the company insisting its naval strategy — encompassing systems such as the TRS-4D radar and the Lockheed Martin cooperation — remains intact.

Political Backing and a Pipeline Still Building

The growth narrative continues to draw support from official quarters. Defence Minister Pistorius visited Hensoldt in July, praising the company as a “reliable partner,” while Economy Minister Reiche pointed to its “sustainable growth” as evidence of robust demand. Management’s own assessment now characterises the European defence market as constrained not by budgets but by capacity — a view buttressed by the NATO summit in Ankara and multi-year investment cycles.

The pipeline offers further reason for optimism. The FREYJA air defence programme, a second tranche of PEGASUS with a potential value of around €900 million, and the Eurofighter ECRS Mk1 programme — with €580 million already booked — all feature among the opportunities management is tracking.

Yet the market has proven resistant to such reassurances. Even JPMorgan’s decision roughly a month ago to lift its price target failed to arrest the decline, with the stock shedding more than ten percent since. The announcement of a new development centre near Stuttgart, to be built jointly with Bosch and creating around 300 jobs, likewise provided no lasting support.

Insider Selling Adds to the Caution

Adding to the sombre mood was an insider transaction in mid-August. Reiner Winkler, chairman of the supervisory board, sold 10,000 shares on 18 August at €94.71 each, a transaction worth roughly €947,000. The stock slipped 1.33 percent to €93.64 in the aftermath.

With a 30-day annualised volatility of 39 percent, Hensoldt remains a stock for risk-tolerant investors. The next significant test arrives on 5 November, when the company reports its nine-month figures. Until then, the central question persists: whether record operational performance can eventually outweigh the sector’s prevailing anxiety and restore the confidence that has evaporated since the autumn peak.